Filing a Taxotere case
Currently there isinterdistrict litigationconsolidated in the Eastern District of Louisiana. The Taxotere lawsuit consists of women who have developed alopecia after using Taxotere.
If you are currently suffering from permanent hair loss and have been previously prescribed Taxotere, contact TorHoerman Law Firm today for a free, no-obligation Taxotere assessment and court consultation.
Our dedicated team ofbad drug advocateswill be here to help you every step of the way, answering all your questions and guiding you through the steps of your Taxotere process.
If you think you may qualify to participate in a Taxotere procedure, this is the first step you should takereduce injuriesand possible future damages. In order to adequately mitigate the cost, seek appropriate medical treatment promptly and follow your doctor's instructions.
Then you should familiarize yourself with itcivil processso you know what will come out of your Taxotere process.
Hiring a Personal Injury AttorneyActing as your Taxotere lawyer is an important step.
Be sure to ask plenty of questions about your potential attorney's experience, salary structure, and anything else you think is important.
Hire a Taxotere lawyer
Your Taxotere lawyer will work to build a strong case to prove thisResponsibilityfor your injuries lies with the manufacturer.
Your Taxotere lawyer will take care of thisgather evidenceshow responsibilityassess damagethat you have suffered from your injuries, filing legal documents on your behalf and working to earn themDamage paymentfor his injuries in the form of a settlement or judgment.
from your stateState of Restrictionslimits the time you have to file a Taxotere claim after your injuries have become apparent and/or diagnosed. Therefore, contact a Taxotere lawyer as soon as possible to start the legal dispute.
How common is permanent hair loss in Taxotere?
Temporary hair loss is a common side effect of most chemotherapy treatments.
However, most do not cause complete hair loss.
Studies have shown that of all the side effects of chemotherapy, temporary hair loss has the greatest impact on patients' quality of life.
Taxotere has been linked to alopecia, permanent hair loss, in patients taking the drug for chemotherapy treatment.
Alopecia is permanent and irreversible hair loss that affects all body hair, including:
- eyebrows
- eyelash
- facial hair
- pubic hair
Several studies have found that using Taxotere can lead to alopecia.
Indications of alopecia in Taxotere patients are:
- documents fromGEICAM 9805 study funded by Sanofi-- which was presented as evidence in an ongoing lawsuit against Sanofi showing that approximately 9.2% of patients had hair loss that lasted more than a decade.
- A 2006 study by theRock Mountain Cancer Centerswho found that Taxotere caused 6% of women to suffer from permanent alopecia.
- AStudy published in 2012 in the Annals of Oncology. Of the 20 female participants who received Taxotere, 19 developed permanent hair loss. One participant being treated for recurrent breast cancer had previously received chemotherapy with another drug and had complete hair regrowth, but suffered permanent hair loss after using Taxotere.
Alopecia can seriously affect a person's quality of life, affecting body image and causing depression and distress.
For women already struggling with breast cancer and chemotherapy, developing alopecia can be devastating.
For breast cancer survivors, alopecia is more than a cosmetic effect.
The disease is a constant reminder to fight breast cancer.
The 2012 study, published in the Annals of Oncology, found that women who suffered from alopecia due to Taxotere experienced a "significant impairment" in their quality of life.
Taxotere Treatment Plan
Unlike similar chemotherapy drugs with weekly treatment schedules, the Taxotere treatment schedule runs in three-week intervals.
Fewer doctor visits for treatment make Taxotere more attractive to patients and doctors alike.
Taxotere is also approved for non-hospital use (at doses of 60-100 mg/m2).
Similar chemotherapy treatments require hospitalization to cope with prolonged infusion times.
As warned on the Taxotere label, toxic death occurs in about 2% of patients with metastatic breast cancer and about 11.5% of patients with other types of tumors with abnormal liver function who take Taxotere.
TorHoerman Law - Hair Loss Lawyers in Taxotere
TorHoerman Law has a dedicated team of anti-drug attorneys experienced in litigating on behalf of individuals who have suffered injuries and losses through no fault of their own.
Our law firm offers free, no-obligation case consultations for anyone needing legal advice and advice regarding Taxotere hair loss and other Taxotere-related injuries.
We work in onecontingency fee basisTherefore, our clients never pay legal fees until they receive compensation.
No compensation? duty free
So contact TorHoerman Law, your hair loss attorney at Taxotere, and find out how we can serve you today.
What are the long term effects of Taxotere?
Along with the more common side effects, there are also more life-threatening side effects associated with Taxotere.
Taxotere bears aBlack box warningfor several known adverse health effects associated with the drug.
ThisBlack Box adverse health effects include:
Toxic Death
Increased risk for patients with:
- abnormal liver function
- Patients prescribed higher doses
- Patients with NSCLC
- Previous recipients of platinum-based therapy
hepatotoxicity
Liver damage from exposure to chemicals resulting from treatment with Taxotere.
Hepatotoxicity can cause serious and even life-threatening complications.
Hepatotoxicity is common in patients with:
- abnormal liver function
- high LFT
fluid retention
Taxotere's label warns that the condition can become serious in some patients.
neutropenia
A low neutrophil (specific white blood cell) count makes patients more likely to get bacterial infections.
If left untreated, these bacterial infections can lead to serious health problems and even death.
Patients with neutrophil counts below 1500 cells per 3 cubic millimeters blood volume are more likely to develop neutropenia and are advised not to use Taxotere unless necessary.
Doctors are advised to frequently monitor blood counts with Taxotere in these patients.
hypersensitivity reactions
Reactions such as rash, low blood pressure and fatal anaphylaxis.
Patients who received dexamethasone premedication are more prone to developing these diseases.
What is the status of the Taxotere campaign?
A growing number of women and their families have filed lawsuits against Taxotere's maker, Sanofi, and some generic drug companies, claiming that the manufacturers were aware of the increased risks of alopecia but failed to warn consumers.
The plaintiffs also allege that Sanofi withheld data and research linking Taxotere to these adverse side effects.
In fact, Sanofi warned non-US consumers that Taxotere could be linked to "permanent hair loss" and even alopecia, but failed to warn US consumers.
Evidence filed in a lawsuit against Sanofi suggests the manufacturer tried to downplay known risks to get the drug approved in 1996.
The plaintiffs allege that staff training included a misrepresentation of safety and efficacy doctrine and alleged illegal payments in the form of "kickbacks" to physicians who prescribed Taxotere.
Lawsuits allege that Sanofi actually misled the US public through advertising and marketing that reassured Taxotere users that the hair loss was temporary and that there was no threat of permanent hair loss.
Plaintiffs allege that Sanofi also failed to acknowledge internal data from the GEICAM 9805 study, which showed that approximately 9.2% of patients had hair loss that lasted more than 10 years and that Sanofi used the doctor's findings does not acknowledge Scott Sedlack of Rocky Mountain Cancer Centers, whose results showed that 6% of women taking Taxotere developed permanent alopecia.
While studies suggest that Taxotere is an effective chemotherapy regimen, court cases claim that other treatments at least as effective as Taxotere do not expose consumers to the same risks of permanent hair loss.